Columbus Circle Investors’s bluebird bio BLUE Stock Holding History
Bought
Maintained
Sold
Other funds holding BLUE
Columbus Circle Investors's BLUE Position: Q1 2018 in Review
Columbus Circle Investors sold out of bluebird bio (BLUE) in Q1 2018, closing a stake of 10,151 shares — an estimated $23.4M sold.
Columbus Circle Investors first reported a position in BLUE in Q3 2014 and held it in 14 quarters. The position peaked at $31.7M in Q1 2015. 303 funds tracked by Wall St. Rank hold BLUE as of Q1 2018.
- Columbus Circle Investors reported no remaining bluebird bio position as of Q1 2018 after selling out during the quarter.
- Columbus Circle Investors sold 10,151 bluebird bio shares in Q1 2018, an estimated $23.4M.
- Columbus Circle Investors first reported a position in bluebird bio in Q3 2014 and held it in 14 quarters.
- Columbus Circle Investors's bluebird bio position peaked at $31.7M in Q1 2015.
- 303 funds tracked by Wall St. Rank held bluebird bio as of Q1 2018.
Based on Columbus Circle Investors's 13F filing for Q1 2018, filed 9 May 2018.